PCAB — Pharmacy Compounding Accreditation Board — accreditation is one of the more confusing pieces of the compounding regulatory landscape because it isn’t actually a government requirement. It’s a voluntary, third-party accreditation, currently administered by ACHC, that has become close to mandatory in practice for pharmacies that want hospital contracts, payer network access, or referrals from prescribers who specifically look for accredited compounders. Here’s what it actually covers and how it fits alongside state licensing and USP compliance.
PCAB accreditation is not the same as state licensing
State boards of pharmacy license compounding pharmacies to operate, and that licensing already requires compliance with applicable USP chapters — USP 795 for non-sterile compounding, USP 797 for sterile compounding, and USP 800 for hazardous drug handling. That licensing is mandatory; you cannot legally compound without it.
PCAB accreditation sits on top of that baseline. It’s a voluntary process where an outside accrediting body reviews the pharmacy’s facilities, processes, personnel training, and quality systems against a standard that’s generally more detailed and more rigorously verified than what a routine state board inspection covers. A pharmacy can be fully licensed and compliant with state law without ever pursuing PCAB accreditation — plenty operate that way. But accreditation has increasingly become a practical requirement for specific business relationships, even though no state currently mandates it as a condition of licensure.
Why pharmacies pursue it anyway
The driving forces are mostly downstream of state regulation:
- Hospital and health system contracts — many hospitals require outsourcing facilities and even smaller compounders they source from to carry current accreditation before they’ll add them as an approved vendor
- Payer and PBM network requirements — some payers use accreditation status as a network inclusion criterion, particularly for specialty and sterile compounded products
- 503B outsourcing facility status — while 503B registration with the FDA is a separate federal designation from PCAB accreditation, many 503B facilities pursue accreditation as an additional credibility marker, since 503B status alone doesn’t verify quality systems the way accreditation review does
- Payer/insurer risk management — accreditation gives insurers and referring providers a third-party verification point instead of relying solely on the pharmacy’s self-reported compliance
This mirrors the dynamic covered in our specialty pharmacy accreditation guide — accreditation in general has become a market-access requirement even where it isn’t a legal one, because it lets payers and referral sources outsource their due diligence to a recognized third party.
What the accreditation process actually reviews
While the exact process differs somewhat depending on whether the pharmacy is pursuing 503A or 503B-track accreditation, the general structure involves an application and self-assessment phase, document review of policies and procedures, an on-site survey by trained surveyors, and an accreditation decision — typically valid for a multi-year cycle with ongoing compliance expectations in between. Surveyors generally look at facility design and environmental controls, personnel training and competency documentation, quality assurance and quality control procedures, beyond-use dating practices, and incident/complaint handling systems. Because accrediting bodies periodically update their standards, don’t assume a checklist from a prior cycle is current — confirm the active standard version with the accrediting body before preparing for survey.
How this relates to sterile compounding specifically
For pharmacies doing sterile compounding, PCAB accreditation overlaps significantly with — but doesn’t replace — the training and competency requirements covered in our piece on sterile compounding training requirements. Accreditation surveyors will typically review the same personnel competency documentation (gowning qualification, media-fill testing, aseptic technique validation) that USP 797 compliance already requires at the state level, but they’re independently verifying it rather than relying on the pharmacy’s internal attestation. A pharmacy with weak documentation practices around USP 797 competency testing will generally struggle with PCAB survey regardless of how sound its actual compounding practices are.
What it costs and how long it takes
Accreditation involves both direct costs (application and survey fees, which vary based on pharmacy size, service lines, and whether multiple locations are being surveyed) and indirect costs — staff time preparing documentation, addressing any gaps identified during self-assessment, and potentially facility or process changes to meet the standard. Timeline from initial application to accreditation decision commonly runs several months, longer if significant corrective action is needed after the initial survey. These figures vary by accrediting body and pharmacy scope, so get current pricing and timeline estimates directly from ACHC rather than relying on older published figures.
Bottom line
PCAB accreditation is not a state licensing requirement anywhere currently, but it has become a practical necessity for compounding pharmacies pursuing hospital, health system, or payer relationships. It sits alongside — not instead of — state licensing and USP chapter compliance, which remain mandatory regardless of accreditation status. Confirm current standards, costs, and process details directly with the accrediting body, and check with your state board on how (if at all) accreditation status interacts with your state compounding license.
RxByState tracks state compounding pharmacy licensing and USP compliance requirements across all 50 states, giving you one place to confirm the regulatory baseline your accreditation efforts sit on top of. Start a free 14-day trial →